Thuy Thai, Ph.D., M.P.H.
Assistant Scientist
Department:
Pharmaceutical Outcomes & Policy
Business Email:
thuythai@ufl.edu
About Thuy Thai
Dr. Thai is an Assistant Scientist within the Department of Pharmaceutical Outcomes and Policy (POP). She earned her pharmacy training at the University of Medicine and Pharmacy in Ho Chi Minh City, Vietnam. She then received her Master of Public Health in Epidemiology from the University of Georgia. In the spring of 2022, she completed her PhD at the POP Department, specializing in pharmacoepidemiology. Her experience includes linking Medicaid data to state vital statistics data, which provides the establishment of rich and comprehensive data sources for pregnancy research. She also specializes in building mother-infant linkages and estimating the timing of pregnancy start date. She has developed pregnancy cohorts within automated real-world healthcare data to support valid inferences about drug effects. Her research focuses on enhancing infrastructures and methodologies and accelerating evidence generation on the safety and effectiveness of medication use during pregnancy.
Publications
Academic Articles
2024
Antihypertensive utilization patterns among pregnant persons with pre-existing hypertension in the US: A population-based study.
PloS one.
19(7)
[DOI] 10.1371/journal.pone.0306547.
[PMID] 38959230.
2024
Common teratogenic medication exposures-a population-based study of pregnancies in the United States.
American journal of obstetrics & gynecology MFM.
6(1)
[DOI] 10.1016/j.ajogmf.2023.101245.
[PMID] 38061552.
2024
Core concepts in pharmacoepidemiology: Measurement of medication exposure in routinely collected healthcare data for causal inference studies in pharmacoepidemiology.
Pharmacoepidemiology and drug safety.
33(3)
[DOI] 10.1002/pds.5683.
[PMID] 37752827.
2024
Development and Validation of an Algorithm to Predict Stillbirth Gestational Age in Medicaid Billing Records.
American journal of epidemiology.
[DOI] 10.1093/aje/kwae369.
[PMID] 39307537.
2024
Prenatal Care Initiation and Exposure to Teratogenic Medications.
JAMA network open.
7(2)
[DOI] 10.1001/jamanetworkopen.2023.54298.
[PMID] 38300617.
2024
Prenatal Exposure to Valproic Acid Across Various Indications for Use.
JAMA network open.
7(5)
[DOI] 10.1001/jamanetworkopen.2024.12680.
[PMID] 38776082.
2024
Teratogenic Risk Impact and Mitigation (TRIM): Study Protocol for the Development of a Decision Support Tool to Prioritize Medications for Risk Mitigation.
Drug safety.
[DOI] 10.1007/s40264-024-01488-4.
[PMID] 39499480.
2024
Triple challenges-small sample size in both exposure and control groups to scan rare maternal outcomes in a signal identification approach: a simulation study.
American journal of epidemiology.
193(12):1805-1813
[DOI] 10.1093/aje/kwae151.
[PMID] 38918039.
2024
Use of Prescription Antiemetics Among US Commercially Insured Pregnant Patients, 2005-2019.
JAMA network open.
7(10)
[DOI] 10.1001/jamanetworkopen.2024.40414.
[PMID] 39436650.
2023
Development and Validation of Algorithms to Estimate Live Birth Gestational Age in Medicaid Analytic eXtract Data.
Epidemiology (Cambridge, Mass.).
34(1):69-79
[DOI] 10.1097/EDE.0000000000001559.
[PMID] 36455247.
2023
IMPACT OF CONTINUOUS MATERNAL ENROLLMENT ON STILLBIRTH GESTATIONAL AGE DISTRIBUTIONS AND MATERNAL CHARACTERISTICS AMONG MEDICAID ENROLLEES.
American journal of epidemiology.
192(3):497-502
[DOI] 10.1093/aje/kwac206.
[PMID] 36482740.
2023
Risk of fetal or neonatal death or neonatal intensive care unit admission associated with gadolinium magnetic resonance imaging exposure during pregnancy.
American journal of obstetrics and gynecology.
228(4):465.e1-465.e11
[DOI] 10.1016/j.ajog.2022.10.005.
[PMID] 36241080.
2023
Validation of an ICD-9-Based Algorithm to Identify Stillbirth Episodes from Medicaid Claims Data.
Drug safety.
46(5):457-465
[DOI] 10.1007/s40264-023-01287-3.
[PMID] 37043168.
2022
CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention in Diverse Clinical Settings.
Journal of the American Heart Association.
11(4)
[DOI] 10.1161/JAHA.121.024159.
[PMID] 35156424.
2022
Prenatal exposure to teratogenic medications in the era of Risk Evaluation and Mitigation Strategies.
American journal of obstetrics and gynecology.
227(2):263.e1-263.e38
[DOI] 10.1016/j.ajog.2022.01.004.
[PMID] 35032444.
2021
An evaluation of co-use of chloroquine or hydroxychloroquine plus azithromycin on cardiac outcomes: A pharmacoepidemiological study to inform use during the COVID19 pandemic.
Research in social & administrative pharmacy : RSAP.
17(1):2012-2017
[DOI] 10.1016/j.sapharm.2020.04.031.
[PMID] 32409150.
2020
Impact of the Transition from ICD-9-CM to ICD-10-CM on the Identification of Pregnancy Episodes in US Health Insurance Claims Data.
Clinical epidemiology.
12:1129-1138
[DOI] 10.2147/CLEP.S269400.
[PMID] 33116906.
2020
Predicting the probability of survival with mild or moderate neurological dysfunction after in-hospital cardiopulmonary arrest: The GO-FAR 2 score.
Resuscitation.
146:162-169
[DOI] 10.1016/j.resuscitation.2019.12.001.
[PMID] 31821836.
2020
Risk of pregnancy loss in patients exposed to mycophenolate compared to azathioprine: A retrospective cohort study.
Pharmacoepidemiology and drug safety.
29(6):716-724
[DOI] 10.1002/pds.5017.
[PMID] 32347619.
2020
Updating the Cost Effectiveness of Oral Anticoagulants for Patients with Atrial Fibrillation Based on Varying Stroke and Bleed Risk Profiles.
PharmacoEconomics.
38(12):1333-1343
[DOI] 10.1007/s40273-020-00960-0.
[PMID] 32924092.
2019
Central Nervous System Effects of Oral Propranolol for Infantile Hemangioma: A Systematic Review and Meta-Analysis.
Journal of clinical medicine.
8(2)
[DOI] 10.3390/jcm8020268.
[PMID] 30813242.
2019
Developing and validating the Personal Risk of Oncogenic Human Papillomavirus infection score in US Women.
Family practice.
36(4):395-401
[DOI] 10.1093/fampra/cmy091.
[PMID] 30239658.
2019
Prospective validation of the Good Outcome Following Attempted Resuscitation (GO-FAR) score for in-hospital cardiac arrest prognosis.
Resuscitation.
140:2-8
[DOI] 10.1016/j.resuscitation.2019.05.002.
[PMID] 31078496.
2018
Cancer screening recommendations: an international comparison of high income countries.
Public health reviews.
39
[DOI] 10.1186/s40985-018-0080-0.
[PMID] 29507820.
2018
Comments on the article “Effectiveness and safety of tofacitinib in rheumatoid arthritis: a cohort study”.
Arthritis research & therapy.
20(1)
[DOI] 10.1186/s13075-018-1651-7.
[PMID] 30157957.
2018
Signs and symptoms of Group A versus Non-Group A strep throat: A meta-analysis.
Family practice.
35(3):231-238
[DOI] 10.1093/fampra/cmx072.
[PMID] 29045629.
2017
Prevalence of and Risk Factors for Oral Human Papillomavirus Infection With Multiple Genotypes in the United States.
Sexually transmitted diseases.
44(3):166-172
[DOI] 10.1097/OLQ.0000000000000563.
[PMID] 28178115.
2016
Association Between Vaginal Douching and Genital Human Papillomavirus Infection Among Women in the United States.
The Journal of infectious diseases.
214(9):1370-1375
[PMID] 27553042.
2016
Prevalence of Atypical Pathogens in Patients With Cough and Community-Acquired Pneumonia: A Meta-Analysis.
Annals of family medicine.
14(6):552-566
[DOI] 10.1370/afm.1993.
[PMID] 28376442.
Education
Doctor of Philosophy
2022
·
University of Florida
Master of Public Health
2017
·
University of Georgia
Bachelor of Pharmacy
2014
·
University of Medicine and Pharmacy Ho Chi Minh City
Contact Details
Emails:
- Business:
- thuythai@ufl.edu
Addresses:
- Business Mailing:
-
PO Box 100496
GAINESVILLE FL 32610 - Business Street:
-
1225 CENTER DRIVE, HPNP
GAINESVILLE FL 32610